These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 25223735)
81. PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth. Sharma N; Nanta R; Sharma J; Gunewardena S; Singh KP; Shankar S; Srivastava RK Oncotarget; 2015 Oct; 6(31):32039-60. PubMed ID: 26451606 [TBL] [Abstract][Full Text] [Related]
82. PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer. Zhang X; Zeng Y; Qu Q; Zhu J; Liu Z; Ning W; Zeng H; Zhang N; Du W; Chen C; Huang JA Int J Clin Oncol; 2017 Dec; 22(6):1026-1033. PubMed ID: 28748356 [TBL] [Abstract][Full Text] [Related]
83. PGC1-α-driven mitochondrial biogenesis contributes to a cancer stem cell phenotype in melanoma. Fontana F; Macchi C; Anselmi M; Rizzuto AS; Ruscica M; Limonta P Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166897. PubMed ID: 37758066 [TBL] [Abstract][Full Text] [Related]
84. Natural killer cells kill human melanoma cells with characteristics of cancer stem cells. Pietra G; Manzini C; Vitale M; Balsamo M; Ognio E; Boitano M; Queirolo P; Moretta L; Mingari MC Int Immunol; 2009 Jul; 21(7):793-801. PubMed ID: 19491215 [TBL] [Abstract][Full Text] [Related]
85. Mechanotransduction in cancer stem cells. Hao J; Zhang Y; Ye R; Zheng Y; Zhao Z; Li J Cell Biol Int; 2013 Sep; 37(9):888-91. PubMed ID: 23576457 [TBL] [Abstract][Full Text] [Related]
86. Targeting melanoma stem cells with the Vitamin E derivative δ-tocotrienol. Marzagalli M; Moretti RM; Messi E; Marelli MM; Fontana F; Anastasia A; Bani MR; Beretta G; Limonta P Sci Rep; 2018 Jan; 8(1):587. PubMed ID: 29330434 [TBL] [Abstract][Full Text] [Related]
87. Circular RNA has circ 0001591 promoted cell proliferation and metastasis of human melanoma via ROCK1/PI3K/AKT by targeting miR-431-5p. Yin D; Wei G; Yang F; Sun X Hum Exp Toxicol; 2021 Feb; 40(2):310-324. PubMed ID: 32830578 [TBL] [Abstract][Full Text] [Related]
88. Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem-like Cells in an Akt/Foxo3a/TRAIL-Dependent Manner. Prabhu VV; Allen JE; Dicker DT; El-Deiry WS Cancer Res; 2015 Apr; 75(7):1423-32. PubMed ID: 25712124 [TBL] [Abstract][Full Text] [Related]
89. FOXC1 promotes melanoma by activating MST1R/PI3K/AKT. Wang J; Li L; Liu S; Zhao Y; Wang L; Du G Oncotarget; 2016 Dec; 7(51):84375-84387. PubMed ID: 27533251 [TBL] [Abstract][Full Text] [Related]
90. Activation of the PI3K/AKT signalling pathway in non-melanoma skin cancer is not mediated by oncogenic PIK3CA and AKT1 hotspot mutations. Hafner C; Landthaler M; Vogt T Exp Dermatol; 2010 Aug; 19(8):e222-7. PubMed ID: 20557351 [TBL] [Abstract][Full Text] [Related]
91. Targeting PI3K/Akt/mTOR Pathway Identifies Differential Expression and Functional Role of IL8 in Liver Cancer Stem Cell Enrichment. Kahraman DC; Kahraman T; Cetin-Atalay R Mol Cancer Ther; 2019 Nov; 18(11):2146-2157. PubMed ID: 31439713 [TBL] [Abstract][Full Text] [Related]
92. MYH9 is a novel cancer stem cell marker and prognostic indicator in esophageal cancer that promotes oncogenesis through the PI3K/AKT/mTOR axis. Kai JD; Cheng LH; Li BF; Kang K; Xiong F; Fu JC; Wang S Cell Biol Int; 2022 Dec; 46(12):2085-2094. PubMed ID: 36030536 [TBL] [Abstract][Full Text] [Related]
93. 6-Mercaptopurine attenuates tumor necrosis factor-α production in microglia through Nur77-mediated transrepression and PI3K/Akt/mTOR signaling-mediated translational regulation. Huang HY; Chang HF; Tsai MJ; Chen JS; Wang MJ J Neuroinflammation; 2016 Apr; 13(1):78. PubMed ID: 27075886 [TBL] [Abstract][Full Text] [Related]
94. Uveal melanoma cell lines contain stem-like cells that self-renew, produce differentiated progeny, and survive chemotherapy. Kalirai H; Damato BE; Coupland SE Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8458-66. PubMed ID: 21896849 [TBL] [Abstract][Full Text] [Related]
95. Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN. Han M; Liu M; Wang Y; Chen X; Xu J; Sun Y; Zhao L; Qu H; Fan Y; Wu C PLoS One; 2012; 7(6):e39520. PubMed ID: 22761812 [TBL] [Abstract][Full Text] [Related]
96. The combination of NVP-BKM120 with trastuzumab or RAD001 synergistically inhibits the growth of breast cancer stem cells in vivo. Yu F; Zhao J; Hu Y; Zhou Y; Guo R; Bai J; Zhang S; Zhang H; Zhang J Oncol Rep; 2016 Jul; 36(1):356-64. PubMed ID: 27175939 [TBL] [Abstract][Full Text] [Related]
97. Odontogenic ameloblast-associated protein (ODAM) inhibits growth and migration of human melanoma cells and elicits PTEN elevation and inactivation of PI3K/AKT signaling. Foster JS; Fish LM; Phipps JE; Bruker CT; Lewis JM; Bell JL; Solomon A; Kestler DP BMC Cancer; 2013 May; 13():227. PubMed ID: 23648148 [TBL] [Abstract][Full Text] [Related]
98. Long non-coding RNA HOTAIR promotes UVB-induced apoptosis and inflammatory injury by up-regulation of PKR in keratinocytes. Liu G; Zhang W Braz J Med Biol Res; 2018 Jun; 51(8):e6896. PubMed ID: 29898032 [TBL] [Abstract][Full Text] [Related]
99. RhoC promotes human melanoma invasion in a PI3K/Akt-dependent pathway. Ruth MC; Xu Y; Maxwell IH; Ahn NG; Norris DA; Shellman YG J Invest Dermatol; 2006 Apr; 126(4):862-8. PubMed ID: 16470169 [TBL] [Abstract][Full Text] [Related]
100. Stem cells in melanoma development. Sabatino M; Stroncek DF; Klein H; Marincola FM; Wang E Cancer Lett; 2009 Jul; 279(2):119-25. PubMed ID: 19095348 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]